Please login to the form below

Not currently logged in
Email:
Password:

insulin

This page shows the latest insulin news and features for those working in and with pharma, biotech and healthcare.

Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline

Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline

Weinand, a US citizen, has clearly been drafted in to help address the decline in Sanofi’s revenues in American, where its flagship insulin and diabetes products are under pricing pressure

Latest news

More from news
Approximately 72 fully matching, plus 471 partially matching documents found.

Latest Intelligence

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    As biosimilars surge into the insulin market, governments  are urged to seize ‘the opportunity of the century’. ... With insulin, we  are creating new educational and awareness programmes based on the fact that biosimilars come at a better value

  • Managing medication non-adherence Managing medication non-adherence

    One Drop, the digital diabetes mHealth app, has recently shown that AC1 levels are reduced by 1% in people using the app to track their insulin, glucose, activity and food.

  • When science is not enough When science is not enough

    Destructive. Given that Pfizer had to pull its powder-based insulin drug Exubera after it had returned just $13m in sales from an 11-year $2.8bn development project, it seems

  • Deal Watch May 2016 Deal Watch May 2016

    Similarly, Bristol-Myers Squibb has called time on its deal with Biocon for IN-105/Tregopil [oral insulin].

  • Harnessing commercial innovation Harnessing commercial innovation

    We needed to ensure that people were safe. Then we needed to ensure that our insulin was made available to people in Japan. ... From our own point of view, we need to ensure that our devices have connectivity - you need to be able to store and transfer

More from intelligence
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    Manufacturing for these products is going to look very different to the process used for large-scale production of biotech products, like recombinant insulin.” Ivan explains. “

  • CES 2017 – Medical Device Top Picks

    CES 2017 – Medical Device Top Picks. Connected tech was the overriding theme at this year's Consumer Electronics Show in Las Vegas. But among all that consumer gadgetry, there were some great medical devices too. So what are the ones to watch in

  • Could hackers threaten your health?

    cybersecurity. After being hit by recent discoveries of security flaws in on-the-market insulin pumps, pacemakers, and infusion pumps, cyber security researchers and medical suppliers are even considering a “ Hippocratic

  • Blog: Digital therapeutics: within our reach?

    Clipsulin device: automatically counts and transmits the number of injected doses of insulin to your mobile phone, helping you to keep track of your treatment.

  • Pegasus

    Liz Skrbkova - Global Communications Manager, Modern Insulins &Devices, Novo Nordisk Global:. “

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics